Product Name: Glucose 5% Intravenous Infusion Main ingredients and chemical name: Glucose Structural formula:
Molecular formula : C6H12O6·H2O Molecular weight: 198.17 CharacterThe product is a colorless, or almost colorless clear liquid, with sweet flavor. Pharmacology and toxicity Glucose is one of the heat origin for human body, 16.7kJ heat can be produced from one gram glucose, so glucose is usually be used for the supplement of heat and treatment of hypoglycaemia. When administered together with some drug by phleboclysis, because the synthesis of glucogen must be joined with potassium, thus the potassium enter into cell to make the concentration of potassium-plasma decreased, the glucose injection can be used for the treatment of hyperpotassemia. Glucose injection is administered fast intravenously can make tissue dehydrate, so the product can be used as dehydrating agent. Moreover, glucose is main material which can maintain and adjust osmotic pressure of peritoneum dialysate. Pharmacokinetics Glucose administered by phleboclysis usually enter the blood circulation directly. It is oxidized completely to produce CO2 and H2O and excreted by lung and kidney, accompanied with the production of heat. Available capacity of common people for glucose is about 6mg/kg/minute. Indications (1)Used for supplement of energy and body liquid; used for the scarcity of feeding and body liquid caused by all cases (such as vomiting, diarrhea ), intravenous hyperalimentation,ketosis; (2)hypoglycaemia; (3)hyperpotassemia; (4)Hypertonic solution could be used as dehydrant for body tissue.; (5)Used for the preparation of peritoneum dialyszte; (6)Used as medicine diluent; (7)Used for the test of dosis tolerate of glucose administered by phleboclysis; (8)Used for the preparation of GIK.
Specification 500ml:25g Storage ConditionStore below 25 ºC. Protect from sunlight. Keep out of reach of children Package500mL PP bottle Manufacturer Name:Shijiazhuang No.4 Pharmaceutical Co., Ltd.
Shijiazhuang No.4 Pharmaceutical Co., Ltd. was established in 1948, now it is a large-sized foreign invested enterprise and comprehensive medicine manufacturer in China, the capital is USD58 million, and with more than 3000 employees. The company can manufacture 7 series medicines of more than 100 kinds and specifications including infusions, capsules, granules, tablets, oral liquids and etc with GMP approval by SFDA of China. For the key product of large volume I.V solution, the yearly output has reached more than 1200 million bottles including 40 million bottles packing with the soft plastic bottles in the dosage of 500 ml/ 250 ml /100ml. Some index such as quality, variety, and yearly output are all in the leading position of this field in China. The products have been sold to some countries and regions in South America, Africa, and Asia.
Complaint
